WASHINGTON (AP) — The Food and Drug Administration is wrestling with how to decide on booster doses of the single-shot Johnson & Johnson COVID-19 vaccine.
Other manufacturers want to offer boosters six months after primary vaccination.
But J&J proposed a range of times, from two months to six months.
In a review posted Wednesday, FDA scientists didn’t reach a firm conclusion, citing shortcomings with J&J’s data.
On Thursday and Friday, an FDA advisory panel will recommend whether to back boosters of both the J&J and Moderna vaccines.
An extra dose of Pfizer’s vaccine already is available to certain Americans.
Looking for more news and information? NewsCenter1 Media Group has you covered go to NC1.TV today for all of your Western South Dakota and Wyoming news today.
